Asian press release distribution

Press Releases for Friday, November 12, 2021

佳明集团控股有限公司公布截至2021年9月30日止之中期业绩 23:53 HKT/SGT

佳明集團控股有限公司公佈截至2021年9月30日止之中期業績 23:52 HKT/SGT

Grand Ming Group Holdings Limited Announces Interim Results for the Six Months Ended 30 September 2021 23:50 HKT/SGT

No Limits, No Blind Obedience, COEE Speaks for Generation Z 22:00 HKT/SGT

Cake Monster Launches Generative Art NFT and P2E Project in Space 21:00 HKT/SGT

Cake Monster Launches Generative Art NFT and P2E Project in Space 21:00 HKT/SGT

谭仔国际2022年上半年收益上升43%至11.81亿港元经调整溢利仍攀升108%至1.47亿港元 20:47 HKT/SGT

譚仔國際2022年上半年收益上升43%至11.81億港元經調整溢利仍攀升108%至1.47億港元 20:46 HKT/SGT

Tam Jai International's Revenue Increases by 43% to HK$1,181 Million and Adjusted Profit Surges by 108% to HK$147 Million in 1H2022 20:45 HKT/SGT

Party Grandpa Retirement Club is launching interesting Grandpa NFTs 20:00 HKT/SGT

Party Grandpa Retirement Club is launching interesting Grandpa NFTs 20:00 HKT/SGT

BYD ADL eBuses Used as VIP Transport for World Leaders at COP26 20:00 HKT/SGT

Celebrations for TOYOTA GAZOO Racing in Bahrain 16:17 HKT/SGT

Eisai: New Phase 3 Data Show Positive Correlation Between ADUHELM Treatment Effect on Biomarkers and Reduction in Clinical Decline in Alzheimer's Disease 15:10 HKT/SGT

君联资本领投图灵量子PreA轮融资 14:40 HKT/SGT

君聯資本領投圖靈量子PreA輪融資 14:39 HKT/SGT

Legend Capital Leads TuringQ Pre-A Funding 14:38 HKT/SGT

Eisai Presents New Analysis of Lecanemab Clinical Efficacy Results from Phase 2b Study at Clinical Trials On Alzheimer's Disease (CTAD) Conference 14:31 HKT/SGT

Eisai: Introduction of Plasma-based Biomarker Screening to Facilitate Identification of Subjects for Phase 3 Ahead 3-45 Trial Presented at Clinical Trials on Alzheimer's Disease (CTAD) Conference 14:03 HKT/SGT

Toyota Announces Production Plans in December 2021, as of November 12 13:40 HKT/SGT

Mastering Clean Hydrogen Live Online Masterclass is Now Open for Registration 13:30 HKT/SGT

TOYOTA、12月生産計画について（11/12時点） 12:00 HKT/SGT

エーザイとバイオジェン、レカネマブの臨床第III相試験の対象者を同定する、初めての血漿中バイオマーカーによる被験者スクリーニングの導入について第14回アルツハイマー病臨床試験会議にて発表 12:00 HKT/SGT

MHIETの産業用小型ディーゼルエンジンが累計生産台数300万台を達成 12:00 HKT/SGT

エーザイとバイオジェン、レカネマブの臨床第IIb相試験の臨床効果に関する新たな解析結果を第14回アルツハイマー病臨床試験会議にて発表 12:00 HKT/SGT

バイオジェンとエーザイ、ADUHELMの臨床第III相試験におけるアルツハイマー病の臨床症状の悪化抑制とバイオマーカーとの正の相関を示す新しいデータを第14回アルツハイマー病臨床試験会議にて発表 12:00 HKT/SGT

NEC、テレビ東京系列4局から次世代のIPマスターシステムを受注 10:00 HKT/SGT

Olympus Launches Venture Capital Fund to Strengthen Medtech Leadership 07:30 HKT/SGT

American Blockchain PAC Launches to Advance Blockchain and Cryptocurrency Innovation in America 07:19 HKT/SGT

Cross-chain Aggregator Cloud NFT Successfully Closes a Seed Round and Announces Pre-sale on 25th of November and Public Sale Waitlist 05:00 HKT/SGT

Cross-chain Aggregator Cloud NFT Successfully Closes a Seed Round and Announces Pre-sale on 25th of November and Public Sale Waitlist 05:00 HKT/SGT

Committed to ESG, Pertamina develops a climate village program 04:00 HKT/SGT

ACN Search:

Avance Clinical Showcases Clinical Excellence at World Orphan Drug Conference in Boston, April 23-25


Home \| About us \| Services \| Partners \| Events \| Login \| Contact us \| Cookies Policy \| Privacy Policy \| Disclaimer \| Terms of Use \| RSS

US: +1 214 890 4418 \| China: +86 181 2376 3721 \| Hong Kong: +852 8192 4922 \| Singapore: +65 6549 7068 \| Tokyo: +81 3 6859 8575